Horiba Ltd. (OTCMKTS:HRIBF – Get Free Report) was the recipient of a large growth in short interest in October. As of October 15th, there was short interest totaling 164,309 shares, a growth of 80.4% from the September 30th total of 91,089 shares. Currently, 0.4% of the company’s stock are sold short. Based on an average daily volume of 2 shares, the short-interest ratio is currently 82,154.5 days.
Horiba Stock Performance
Shares of HRIBF stock remained flat at $137.00 during trading hours on Friday. Horiba has a 52 week low of $73.11 and a 52 week high of $166.67. The company has a quick ratio of 2.14, a current ratio of 2.93 and a debt-to-equity ratio of 0.11. The stock’s 50-day moving average is $143.11 and its 200 day moving average is $139.75. The stock has a market capitalization of $5.75 billion, a P/E ratio of 19.21 and a beta of 0.23.
Horiba (OTCMKTS:HRIBF – Get Free Report) last announced its earnings results on Friday, August 7th. The company reported $2.01 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.28 by $0.73. The company had revenue of $586.15 million for the quarter, compared to analysts’ expectations of $549.25 million. Horiba had a return on equity of 13.28% and a net margin of 11.80%.
About Horiba
HORIBA, Ltd. is a Japan-based manufacturer of measurement and analysis systems. The company develops instruments and related services used to measure physical and chemical properties across automotive, environmental, medical, semiconductor, and scientific research applications.
Its products include automotive emissions analyzers, engine and drivetrain testing systems, environmental monitoring equipment, process control instruments, semiconductor manufacturing tools, particle and elemental analyzers, blood cell counters, and other medical testing systems.
Further Reading
- Five stocks we like better than Horiba
- Marvell Eyes a Swing for the AI Networking Fences as Markets Weigh Lumentum Price Tag
- Exxon’s Refining Profits Soared—Did Chevron Get the Same Windfall?
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
Receive News & Ratings for Horiba Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Horiba and related companies with MarketBeat.com's FREE daily email newsletter.
